Evaluation of tumor heterogeneity of prostate carcinoma by flow-and image DNA cytometry and histopathological grading

Analytical Cellular Pathology

Volumn 20, Issue 1, 2000, Pages 49-62

  Wang, Naming ^a   Wilkin, Claudia ^b   Böcking, Alfred ^b   Tribukait, Bernhard ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

DNA ploidy; Histopathological grade; Prostate cancer; S phase; Tumor heterogeneity

Indexed keywords

ARTICLE; BIOPSY; CARCINOMA; CELL CYCLE; CELL DIVISION; CYTOCHEMISTRY; DIAGNOSTIC IMAGING; FLOW CYTOMETRY; HUMAN; IMAGE CYTOMETRY; MALE; METHODOLOGY; PATHOLOGY; PLOIDY; PROSTATE TUMOR; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL;

BIOPSY; CARCINOMA; CELL CYCLE; CELL DIVISION; DIAGNOSTIC IMAGING; FLOW CYTOMETRY; HISTOCYTOCHEMISTRY; HUMANS; IMAGE CYTOMETRY; MALE; MODELS, STATISTICAL; PATHOLOGY; PLOIDIES; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY;

EID: 0033656727     PISSN: 09218912     EISSN: None     Source Type: Journal    
DOI: 10.1155/2000/489303     Document Type: Article

References (44)

1. S. Aaltomaa, M. Eskelinen and P. Lipponen, Expression of cyclin A and D proteins in prostate cancer and their relation to clinopathological variables and patient survival, Prostate 38 (1999), 175-182.
2. S. Aaltomaa, P. Lipponen, S. Vesalainen, M. Ala-Opas, M. Eskelinen and K. Syrjanen, Value of Ki-67 immunolabelling as a prognostic factor in prostate cancer, Eur. Urol. 32 (1997), 410-415.
3. M. Aihara, T.M. Wheeler, M. Ohon and P.T. Scardino, Heterogeneity of prostate cancer in radical prostatectomy specimens, Urology 43 (1994), 60-66.
4. C.L. Amling, S.E. Lerner, S.K. Martin, J.M. Slezak, M.L. Blute and H. Zincke, Deoxyribonucleic acid ploidy and serum prostate specific antigen predict outcome following salvage prostatectomy for radiation refractory prostate cancer, J. Urol. 161 (1999), 857-862.
5. W. Beyer, Probability and statistics, in: CRC Handbook of Tables for Probability and Statistics, W. Beyer, ed., CRC Press Inc., Boca Raton, FL, 1983, pp. 11-13.
6. A. Böcking, J. Kiehn and M. Heinzel-Wach, Combined histologic grading of prostatic carcinoma, Cancer 50 (1982), 288-294.
7. M. Borre, S.M. Bentzen, B. Nerstrom and J. Overgaard, Tumor cell proliferation and survival in patients with prostate cancer followed expectantly, J. Urol. 159 (1998), 1609-1614.
8. D.G. Bostwick, Gleason grading of prostatic needle biopsies. Correlation with grade in 316 matched prostatectomies, Am. J. Surg. Pathol. 18 (1994), 796-803.
9. W.J. Catalona, A.J. Stein and W.R. Fair, Grading errors in prostatic needle biopsies: relation to the accuracy of tumor grade in predicting pelvic lymph node metastases, J. Urol. 12 (1982), 919-922.
10. L. Cheng, T.J. Sebo, J. Slezak, T.M. Pisansky, E.J. Bergstralh, R.M. Neumann, K.A. Iczkowski, H. Zincke and D.G. Bostwick, Predictors of survival for prostate carcinoma patients treated with salvage radical prostatectomy after radiation therapy, Cancer 83 (1998), 2164-2171.
11. E.D. Crawford, D. Hirano, P.N. Werahera, M.S. Lucia, E.P. DeAntoni, F. Daneshgari, P.N. Brawn, V.O. Speights, J.S. Stewart and G.J. Miller, Computer modeling of prostate biopsy: tumor size and location - not clinical significance -determine cancer detection, J. Urol. 159 (1998), 1260-1264.
12. G. Forsslund, B. Nilsson and A. Zetterberg, Near tetraploid prostate carcinoma. Methodologic and prognostic aspects, Cancer 78 (1996), 1748-1755.
13. J.E. Garnett, R. Oyasu and J.T. Grayhack, The accuracy of diagnostic biopsy specimens in predicting tumor grades by Gleason's classification of radical prostatectomy specimens, J. Urol. 131 (1984), 690-693.
14. D.F. Gleason, Histologic grading of prostate cancer: a perspective, Hum. Pathol. 23 (1992), 273-279.
15. D.F. Gleason and G.T. Mellinger, Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging, J. Urol. 111 (1974), 58-64.
16. D.R. Greene, S.R. Taylor, T.M. Wheeler and P.T. Scardino, DNA ploidy by image analysis of individual foci of prostate cancer: a preliminary report, Cancer Res. 51 (1991), 4084-4089.
17. D.J. Grignon and E.H. Hammond, College of American Pathologists Conference XXVI on clinical relevance of prognostic markers in solid tumors. Report of the Prostate Cancer Working Group, Arch. Pathol. Lab. Med. 119 (1995), 1122-1126.
18. G. Haroske, F. Giroud, A. Reith and A. Bocking, 1997 ESACP consensus report on diagnostic DNA image cytometry. Part I: basic considerations and recommendations for preparation, measurement and interpretation. European Society for Analytical Cellular Pathology, Anal. Cell. Path. 17 (1998), 189-200.
19. M.E. Harper, L. Goddard, D.W. Wilson, S.S. Matanhelia, I.G. Conn, W.B. Peeling and K. Griffiths, Pathological and clinical associations of Ki-67 defined growth fractions in human prostatic carcinoma, Prostate 21 (1992), 75-84.
20. T. Heiden, N. Wang and B. Tribukait, An improved Hedley method for preparation of paraffin-embedded tissues for flow cytometric analysis of ploidy and S-phase, Cytometry 12 (1991), 614-621.
21. K.K. Hodge, J.E. McNeal, M.K. Terris and T.A. Stamey, Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate, J. Urol. 142 (1989), 71-74.
22. E.C. Jones, J. McNeal, N. Bruchovsky and G. de Jong, DNA content in prostatic adenocarcinoma. A flow cytometry study of the predictive value of aneuploidy for tumor volume, percentage Gleason grade 4 and 5, and lymph node metastases, Cancer 66 (1990), 752-757.
23. S. Lundberg, J. Carstensen and I. Rundquist, DNA flow cytometry and histopathological grading of paraffin-embedded prostate biopsy specimens in a survival study, Cancer. Res. 47 (1987), 1973-1977.
24. R.D. Mashal, S. Lester, C. Corless, J.P. Richie, R. Chandra, K.J. Propert and A. Dutta, Expression of cell cycle-regulated proteins in prostate cancer, Cancer Res. 56 (1996), 4159-4163.
25. S.E. Mills and J.E. Fowler, Jr., Gleason histologic grading of prostatic carcinoma. Correlations between biopsy and prostatectomy specimens, Cancer 57 (1986), 346-349.
26. G.P. Murphy, C. Busch, P.A. Abrahamsson, J.I. Epstein, J.E. McNeal, G.J. Miller, F.K. Mostofi, R.B. Nagle, S. Nordling, C. Parkinson et al., Histopathology of localized prostate cancer. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993, Scand. J. Urol. Neph. (Suppl. 162) (1994), 7-42.
27. O. Nativ, H.Z. Winkler, Y. Raz, T.M. Therneau, G.M. Farrow, R.P. Myers, H. Zincke and M.M. Lieber, Stage C prostatic adenocarcinoma: flow cytometric nuclear DNA ploidy analysis, Mayo Clin. Proc. 64 (1989), 911-919.
28. F.P. O'Malley, D.J. Grignon, M. Keeney, N. Kerkvliet and C. McLean, DNA heterogeneity in prostatic adenocarcinoma. A DNA flow cytometric mapping study with whole organ sections of prostate, Cancer 71 (1993), 2797-2802.
29. D. van den Ouden, B. Tribukait, J.H. Blom, S.D. Fossa, K.H. Kurth, F.J. ten Kate, T. Heiden, N. Wang and F.N. Schroder, Deoxyribonucleic acid ploidy of core biopsies and metastatic lymph nodes of prostate cancer patients: impact on time to progression, J. Urol. 150 (1993), 400-406.
30. J. Qian, D.G. Bostwick, S. Takahashi, T.J. Borell, J.A. Brown, M.M. Lieber and R.B. Jenkins, Comparison of fluorescence in situ hybridization analysis of isolated nuclei and routine histological sections from paraffin-embedded prostatic adenocarcinoma specimens, Am. J. Pathol. 149 (1996), 1193-1199.
31. E.T. Ruijter, C.A. van de Kaa, J.A. Schalken, F.M. Debruyne and D.J. Ruiter, Histological grade heterogeneity in multifocal prostate cancer. Biological and clinical implications, J. Pathol. 180 (1996), 295-299.
32. F.H. Schroder, P. Hermanek, L. Denis, W.R. Fair, M.K. Gospodarowicz and M. Pavone-Macaluso, The TNM classification of prostate cancer, Prostate (Suppl. 4) (1992), 129-138.
33. T.V. Shankey, P.S. Rabmovitch, B. Bagwell, K.D. Bauer, R.E. Duque, D.W. Hedley, B.H. Mayall, L. Wheeless and C. Cox, Guidelines for implementation of clinical DNA cytometry. International Society for Analytical Cytology, Cytometry 14 (1993), 472-477.
34. N. Tinari, C. Natoli, D. Angelucci, R. Tenaglia, B. Fiorentino, P. Di Stefano, C. Amatetti, A. Zezza, M. Nicolai and S. Iacobelli, DNA and S-phase fraction analysis by flow cytometry in prostate cancer. Clinicopathologic implications, Cancer 71 (1993), 1289-1296.
35. B. Tribukait, Rapid-flow cytometry of prostatic fine needle aspiration biopsies, in: Prognostic Cytometry and Cytopathology of Prostate Cancer, JP, K, ed., Elsevier Science Publishing, 1989, pp. 236-242.
36. B. Tribukait, Nuclear deoxyribonucleic acid determination in patients with prostate carcinomas: clinical research and application, Eur. Urol. 23 (1993), 64-76.
37. S. Vesalainen, S. Nordling, P. Lipponen, M. Talja and K. Syrjanen, Progression and survival in prostatic adenocarcinoma: a comparison of clinical stage, Gleason grade, S-phase fraction and DNA ploidy, Bri. J. Cancer 70 (1994), 309-314.
38. S.L. Vesalainen, P.K. Lipponen, M.T. Talja, E.M. Alhava and K.J. Syrjanen, Proliferating cell nuclear antigen and p53 expression as prognostic factors in T1-2MO prostatic adenocarcinoma, Inter. J. Cancer 58 (1994), 303-308.
39. T. Visakorpi, Proliferative activity determined by DNA flow cytometry and proliferating cell nuclear antigen (PCNA) immunohistochemistry as a prognostic factor in prostatic carcinoma, J. Pathol. 168 (1992), 7-13.
40. T. Visakorpi, O.P. Kallioniemi, A. Heikkinen, T. Koivula and J. Isola, Small subgroup of aggressive, highly proliferative prostatic carcinomas defined by p53 accumulation, J. Natl. Cancer Inst. 84 (1992), 883-887.
41. T. Visakorpi, O.P. Kallioniemi, I.Y. Paronen, J.J. Isola, A.I. Heikkinen and T.A. Koivula, Flow cytometric analysis of DNA ploidy and S-phase fraction from prostatic carcinomas: implications for prognosis and response to endocrine therapy, Bri. J. Cancer 64 (1991), 578-582.
42. N. Wang, Y. Pan, T. Heiden and B. Tribukait, Fluorescence image cytometry for measurement of nuclear DNA content in surgical pathology, Cytometry 22 (1995), 323-329.
43. M.J. Warzynski, C.E. Soechtig, T.J. Maatman, L.C. Goldsmith, M.A. Grobbel, G.G. Carothers and K.F. Shockley, DNA heterogeneity determined by flow cytometry in prostatic adenocarcinoma - necessitating multiple site analysis, Prostate 27 (1995), 329-335.
44. H.Z. Winkler, L.M. Rainwater, R.P. Myers, G.M. Farrow, T.M. Therneau, H. Zincke and M.M. Lieber, Stage D1 prostatic adenocarcinoma: significance of nuclear DNA ploidy patterns studied by flow cytometry, Mayo Clin. Proc. 63 (1988), 103-112.